Drug Research
$300mn Pledged By Novartis For European Biotherapeutics
The next-generation biotherapeutics will receive $300 million from Novartis, according to the company. To build a fully integrated, dedicated scientific environment to boost its capabilities...
Drug Research
Prior To FDA Prurigo Nodularis Ruling, Dupixent Wins Again
Dupixent, the immunology favourite developed by Sanofi and Regeneron Pharmaceuticals, is still on the rise. It has received back-to-back approvals this year for the treatment...
Drug Research
Long-Awaited Daxxify By Revance Will Compete With Botox
Revance Therapeutics may soon run into an identity problem with a product that is so eagerly awaited that some people mistakenly call it by the...
Drug Research
Introduction of Anti-Evolocumab Antibodies From Bio-Rad
A group of type 1 antibodies recently made available by Bio-Rad Laboratories are intended to prevent the drug evolcumab from attaching to its target, human...
Drug Research
Merck Assesses 5 Years of Keytruda Lung Cancer Research
By demonstrating a massive survival benefit, Keytruda's Keynote-189 study precipitated a turning point in the development of lung cancer medications. Merck & Co. is now...
Drug Research
Modus Therapeutics Enrols First Patient To Explore Sevuparin
The treatment for paediatric patients with severe malaria is being evaluated through research.
The first patient has been enrolled in the SEVUSMART study, according to a...
Drug Research
Non-Viral CRISPR May Potentially Boost Cell And Gene Therapy
A new variation of the CRISPR-Cas9 gene editing system, according to researchers from the Gladstone Institutes and University of California San Francisco (UCSF), enables the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.